Mobidiag Oy announced that it has received €10 million in funding from Autobio Diagnostics Co., Ltd.
December 16, 2018
Share
Mobidiag Oy announced that it has received €10,000,000 in an equity round of funding on December 17, 2018. The transaction involved participation from new investor Autobio Diagnostics Co., Ltd. (SHSE:603658). The transaction has been approved at the 3rd session of the 3rd directorate meeting of the investor.
Autobio Diagnostics Co., Ltd. is a China-based company and mainly engaged in development, manufacture and sales of diagnostics products. The Company's main products include gnostic products, microbiology detection products, and related devices. The immunodiagnostic products include microplate chemiluminescence diagnostic reagents, Enzyme-Linked immunosorbent assay diagnostic reagents, magnetic particle chemiluminescence detection reagents, and colloidal diagnostic reagents. The microbiology detection products include training detection reagents, susceptibility detection reagents and rapid detection reagents. The device products include microplate readers, chemiluminescence immunoassay analyzers, and united testing analyzers. The Company distributes its products in domestic markets.
AUTOBIO DIAGNOSTICS CO., LTD. 
